C07K 2319/43
Containing a flag-tag
Official title: containing a FLAG-tag
C07K2319/43 (Containing a flag-tag) appears on 467 US grants and 790 published applications in this corpus.
Search patents in C07K- Granted patents
- 467
- Published applications
- 790
- Assignees
- 451
- Inventors
- 1,656
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 7 | 0 |
| 1999 | 6 | 0 |
| 2000 | 10 | 0 |
| 2001 | 5 | 0 |
| 2002 | 6 | 21 |
| 2003 | 5 | 17 |
| 2004 | 4 | 11 |
| 2005 | 9 | 19 |
| 2006 | 10 | 13 |
| 2007 | 5 | 14 |
| 2008 | 11 | 13 |
| 2009 | 5 | 21 |
| 2010 | 13 | 18 |
| 2011 | 8 | 10 |
| 2012 | 11 | 21 |
| 2013 | 11 | 16 |
| 2014 | 10 | 35 |
| 2015 | 15 | 34 |
| 2016 | 34 | 33 |
| 2017 | 31 | 34 |
| 2018 | 25 | 53 |
| 2019 | 24 | 49 |
| 2020 | 27 | 50 |
| 2021 | 31 | 57 |
| 2022 | 30 | 52 |
| 2023 | 23 | 54 |
| 2024 | 32 | 67 |
| 2025 | 31 | 48 |
| 2026 | 18 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Utilization of gene targeting antibody fusion proteins to perform in vivo therapeutic gene editing22 Sep 2026US 12,741,035 B2Baylor College of Medicine
- Engineered cells secreting therapeutic enzymes18 Aug 2026US 12,709,739 B2Cartesian Therapeutics, Inc.
- Methods of treating hearing loss using a secreted target protein11 Aug 2026US 12,703,874 B2Akouos, Inc.
- Variant ICOS ligand immunomodulatory proteins and related compositions and methods28 Jul 2026US 12,692,299 B2Alpine Immune Sciences, Inc.
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof30 Jun 2026US 12,668,645 B2ModeX Therapeutics, Inc.
- Chimeric receptors8 Oct 2026US 2026/0306631 A1St. Jude Children?S Research Hospital
- Targeting gpatch8 for treating sf3b1-mutant cancers8 Oct 2026US 2026/0306672 A1Fred Hutchinson Cancer Center
- Chimeric Cytokine Receptors and Methods of Use8 Oct 2026US 2026/0308235 A1
- Switch receptors1 Oct 2026US 2026/0295042 A1Hoffmann-La Roche Inc.
- Recombinant cd47 binding proteins and their use1 Oct 2026US 2026/0297190 A1Molecular Partners AG
Most cited
By later US patents
- Regulation of endogenous gene expression in cells using zinc finger proteins365US 7,013,219 B2Sangamo BioSciences, Inc. · 2006
- Hybridoma and monoclonal antibody for use in an immunoaffinity purification system210US 5,011,912 AImmunex Corporation · 1991
- Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell179US 6,132,992 ABristol-Myers Squibb Company · 2000
- Immunoglobulin chimeric monomer-dimer hybrids165US 7,348,004 B2Syntonix Pharmaceuticals, Inc. · 2008
- Methods for protein labeling based on acyl carrier protein163US 7,666,612 B2(Epfl) Ecole Polytechnique Federale De Lausanne · 2010